Press release
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Insights and Sales Trends 2024
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market SizeThe global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market size is expected to reach US$ 3978.7 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-3C7231/Global_Methicillin_Resistant_Staphylococcus_Aureus_MRSA_Drugs_Market_Insights_and_Forecast_to_2028
The market is mainly driven by the significant applications of Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market. Bactrim, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vancomycin segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market, driven by demand from China, the second largest economy with some signs of stabilising, the Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Key Companies:
• Takeda Pharmaceutical
• Merck
• AstraZeneca
• GlaxoSmithKline
• Pfizer
• Cubist Pharmaceuticals
• ViroPharma
• Forest Laboratories
• Theravance
By Type
• Bactrim
• Vancomycin
• Clindamycin
• Minocycline
By Application
• Hospital
• Clinic
View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-3C7231/global-methicillin-resistant-staphylococcus-aureus-mrsa-drugs
Email Id:
Please reach us at sales@valuates.com
Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Insights and Sales Trends 2024 here
News-ID: 3489368 • Views: …
More Releases from Valuates Reports
Blister Packaging Market Revenue, Insights, Overview, Outlook, Analysis
The global Blister Packaging market size is projected to reach USD 23570 Million by 2027, from USD 17490 Million in 2020, at a CAGR of 5.1% during 2021-2027. Growing demand from end-use industries such as healthcare, food, consumer goods, and industrial goods. Key drivers of the blister packaging market are the growing demand from end-use industries such as healthcare, food, consumer, industrial goods, and various advantages offered by blister packages.…
Digital Comic Book Market Insights, Forecast to 2028
The global Digital Comic Book market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Paid Book accounting for % of the Digital Comic Book global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-6Q10591/Global_Digital_Comic_Book_Market_Insights_Forecast_to_2028
While…
Education ERP Market Research Report 2024
Education ERP (Enterprise Resource Planning) suites contain integrated modules that manage business operations for schools. Much like ERP systems link departments at enterprise businesses, K12 Education ERP suites seamlessly connect functions from an educational institution's "back office" departments, including finance and accounting, human resources, and fee payments.
The global Education ERP market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR…
Managed Services Market Revenue, Insights, Overview, Outlook, Analysis
The global Managed Services market size is projected to reach USD 271640 Million by 2028, from USD 142300 Million in 2021, at a CAGR of 9.2% during 2022-2028.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-1R2135/Global_Managed_Services_Market_Size_Status_and_Forecast_2020_2026
Managed Services Market Market Driving Factors Trends
Enterprises and government agencies around the world are migrating from test environments to cloud and compute instances for more of their mission-critical workloads. Furthermore, the demand for data centers is increasing as a result…
More Releases for Staphylococcus
Methicillin-Resistant Staphylococcus Aureus Testing Market Size, Share, Developm …
LP INFORMATION offers a latest published report on Methicillin-Resistant Staphylococcus Aureus Testing Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Methicillin-Resistant Staphylococcus Aureus Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million…
Staphylococcus Aureus Testing Market In-Depth Market Research Report 2027
A wide range of human clinical infection caused by Staphylococcus Aureus such as Skin, soft tissue, bacteremia, infective endocarditis and others are the major infection caused by Staphylococcus Aureus. The increased use of Staphylococcus Aureus testing in the diagnosis of staph infection grow rapidly, due to the availability of the various advanced test to screen the pathogen efficiently. There is a number of tests present in the market for Staphylococcus…
Methicillin-resistant Staphylococcus Aureus Therapeutics Pipeline Analysis 2018
MRSA infection caused by specific "staph" bacteria that is often resistant to most of antibiotic treatments. S. aureus (SA) is listed as a ‘superbug’ by U.S. Centers for Disease Control and Prevention (CDC). MRSA can either be present harmlessly on the skin (colonization) or enter the body (e.g. through broken skin) and cause an infection. The study analyzed that MRSA infection therapeutics pipeline comprises approximately 52 drug candidates in different…
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market – Driver
Methicillin-Resistant Staphylococcus Aureus (MRSA) is a type of staphylococcus aureus, which became resistant to methicillin, amoxicillin, penicillin, oxacillin, and other such commonly used antibiotics. Staphylococcus aureus harbors on the skin and nasal passage of about one third of the world population, which comprises around 33%, as per Centers for Disease Control and Prevention (CDC) review 2015. MRSA can be classified into two types, based on mode of infection – Hospital…
Vancomycin-Resistant Staphylococcus aureus Infections Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections - Pipeline Review, H1 2017, provides an overview of the Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease) pipeline landscape.
Vancomycin resistant staphylococcus infection is a condition caused by bacteria (germs) . This infection occurs when bacteria, called Staphylococcus aureus or Staph, becomes resistant (not killed) to the antibiotic medicine vancomycin. Risk factors include taking strong antibiotics the wrong…
Market Forecast Report on Staphylococcus Aureus Testing Market 2017 – 2027
A wide range of human clinical infection caused by Staphylococcus Aureus such as Skin, soft tissue, bacteremia, infective endocarditis and others are the major infection caused by Staphylococcus Aureus. The increased use of Staphylococcus Aureus testing in the diagnosis of staph infection grow rapidly, due to the availability of the various advanced test to screen the pathogen efficiently. There is a number of tests present in the market for Staphylococcus…
